肉芽肿性多血管炎患者过渡型和初始B细胞中Bruton酪氨酸激酶活性增强的证据
该研究检测了29例未经治疗的肉芽肿性多血管炎(GPA)患者外周血B细胞亚群中BTK蛋白及磷酸化水平,并与健康对照和活动性类风湿关节炎(RA)患者比较。结果显示活动性GPA和RA患者过渡型和初始B细胞BTK蛋白水平显著升高,且对B细胞受体刺激更敏感;体外BTK阻断可显著抑制B细胞细胞因子产生、浆细胞形成及(自身)抗体产生,但在活动性GPA患者中效果较弱。
要点
- 活动性GPA患者过渡型和初始B细胞BTK蛋白水平显著高于缓解期GPA和健康对照。
- 活动性GPA患者B细胞对BCR刺激更敏感,BTK和PLCγ2磷酸化增加。
- 体外BTK阻断显著抑制GPA患者和健康对照的B细胞效应功能。
核心结论
- 活动性GPA患者新出现的B细胞中BTK蛋白和磷酸化水平显著升高,BTK阻断可抑制B细胞效应功能,提示BTK是GPA治疗的新靶点。
研究设计与样本
- 研究纳入29例未经治疗的GPA患者(9例活动性,20例缓解期,其中10例ANCA阴性、10例ANCA阳性)、9例年龄性别匹配的健康对照和9例未经治疗的活动性RA患者。
- 采用流式细胞术检测外周血B细胞中BTK蛋白和磷酸化水平,并在外周血单个核细胞培养中评估BTK阻断对B细胞细胞因子产生、亚群分布和(自身)抗体产生的影响。
主要发现
- 活动性GPA和RA患者过渡型和初始B细胞中BTK蛋白水平显著高于缓解期GPA患者和健康对照。
- 活动性GPA患者上述B细胞亚群对B细胞受体刺激更敏感,BTK和磷脂酶Cγ2磷酸化水平增加。
- 体外BTK阻断对GPA患者和健康对照的B细胞细胞因子产生、浆细胞形成及(自身)抗体产生均有显著影响。
- BTK阻断在活动性GPA患者中的效果较弱,可能与B细胞活化增强有关。
临床怎么用
- BTK蛋白和磷酸化水平在活动性GPA患者新出现的B细胞中显著升高,或可作为疾病活动相关的B细胞活化标志。
- 体外BTK阻断可抑制GPA患者B细胞效应功能,支持BTK作为GPA潜在治疗靶点进一步研究。
局限性
- 研究为体外实验,样本量有限,BTK阻断在活动性GPA患者中效果较弱的具体机制尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine Bruton's tyrosine kinase (BTK) protein and phosphorylation levels in B cell subsets of granulomatosis with polyangiitis (GPA) patients and to investigate the effect of BTK blockade on in vitro B cell cytokine production, subset distribution and (auto)antibody production. METHODS: BTK protein and phosphorylation levels were determined by flow cytometry in peripheral blood B cells of 29 untreated GPA patients [9 active and 20 remission GPA patients (10 ANCA- and 10 ANCA+)], 9 age- and sex-matched healthy controls (HCs) and 9 untreated active RA patients. The effect of BTK blockade on in vitro B cell cytokine production, subset distribution and (auto)antibody production was determined in the same donors in peripheral blood mononuclear cell cultures. RESULTS: BTK protein levels were significantly increased in transitional and naïve B cells of active GPA and RA patients compared with remission GPA patients and HCs. Both B cell subsets of active patients were more sensitive to B cell receptor stimulation, as BTK and phospholipase Cγ2 phosphorylation were increased in these patients. In vitro BTK blockade had profound effects on B cell cytokine production, plasma cell formation and (auto)antibody production in both GPA patients and HCs. Interestingly, the effect of BTK blockade was less pronounced in active GPA patients, possibly due to increased activation of B cells. CONCLUSION: We show that BTK protein and phosphorylation levels are most profoundly increased in newly emerging B cells of active GPA patients compared with remission patients. BTK blockade greatly inhibits in vitro B cell effector functions in GPA patients and HCs. These promising data identify BTK as an interesting novel therapeutic target in the treatment of GPA.
引用
- von Borstel A, Abdulahad WH, Sanders JS, et al. Evidence for enhanced Bruton's tyrosine kinase activity in transitional and naïve B cells of patients with granulomatosis with polyangiitis. Rheumatology (Oxford). 2019. PMID: 31209475. doi:10.1093/rheumatology/kez205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。